Gland Pharma Rises 21% Over IPO Price On Stock Market Debut
Favipiravir, the antiviral medication being manufactured in Russia. Photographer: Andrey Rudakov/Bloomberg

Gland Pharma Rises 21% Over IPO Price On Stock Market Debut

Shares of Gland Pharma Ltd. soared on its market debut as investors piled in expecting to gain from the demand for its injectables.Shares of the Hyderabad-based drugmaker listed at Rs 1,701 apiece,...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.